New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams

Carbapenem resistance is a major global health problem that seriously compromises the treatment of infections caused by nosocomial pathogens. Resistance to carbapenems mainly occurs via the production of carbapenemases, such as VIM, IMP, NDM, KPC and OXA, among others. Preclinical and clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Vázquez-Ucha, Juan C., Arca-Suárez, Jorge, Bou, Germán, Beceiro, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731173/
https://www.ncbi.nlm.nih.gov/pubmed/33291334
http://dx.doi.org/10.3390/ijms21239308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731173/
https://www.ncbi.nlm.nih.gov/pubmed/33291334
http://dx.doi.org/10.3390/ijms21239308

Ejemplares similares